IU cancer researcher headed to Stanford
An internationally-known breast cancer research is headed west.
Dr. George W. Sledge Jr., who is also a distinguished professor at Indiana University's School of Medicine, is leaving for Stanford University to be the new chief of oncology in Stanford's Department of Medicine, effective Jan. 14, 2013. Sledge is a former president of the American Society for Clinical Oncology and a clinician-scientist focusing on innovative treatments for breast cancer.
Sledge is a co-leader of the Breast Cancer Program at the IU Simon Cancer Center. He has been at the IU School of Medicine for 29 years
This spring, IU named him a distinguished professor. He serves as a physician-scientist at the cancer center and is the Ballve-Lantero professor of oncology, as well as a professor in the IU departments of medicine and in pathology and laboratory medicine.
"The program is not George Sledge. The program is a large and talented group of physicians that we have developed over the years," Sledge said Monday. "Cathy Miller will be taking over my place as head of the breast cancer program. There are four other medical oncologists, each of whom does breast cancer for a living, each of whom is better than the next."
His research interests include targeted therapy related to breast cancer, molecular and tumor biology and growth factors.
Sledge received his medical degree from Tulane University in 1977. He completed his residency at St. Louis University and his fellowship at the University of Texas, San Antonio.
He says despite his new address, he will remain a Colts fan. He says his greatest pain is leaving his patients and their families.